Company

Scipher Medicine

Rocket Ship Rating

Rocket Ship Rating: 98 out of 100

Transforming Treatment in Immunology

Also known as Scipher Medicine Corporation

Biotech & therapeutics
Medical devices & diagnostics
AI native

Status: Operatingas of 2026-09-18
Business model: B2B
Customers: providers and biopharma partnerships
Legal name: Scipher Medicine Corporation

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy.

Funding snapshot

Total raised: $123MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Undisclosed, $30M2026-07-08

Funding rounds

private placement: $30M2026-07-08, Company stated
Round, 2024: $5.8M2024-05-02, SEC form D sold, 1 investor
Round, 2021: $82M2021-03-12, SEC form D sold, 12 investors
Round, 2019: $25M2019-05-08, SEC form D sold, 15 investors
Round, 2018: $8.5M2018-08-03, SEC form D sold, 11 investors
Round, 2018: $795K2018-05-09, SEC form D sold, 5 investors
Round, 2016: $575K2016-10-20, SEC form D sold, 12 investors
Round, 2015: $225K2015-11-05, SEC form D sold, 3 investors

Products

Other: PrismRA
Web: PrismRA
Other: Spectra AI Platform
Web: Spectra AI Platform